CAS 72-63-9|Metandienone
| Common Name | Metandienone | ||
|---|---|---|---|
| CAS Number | 72-63-9 | Molecular Weight | 300.435 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 436.5±45.0 °C at 760 mmHg |
| Molecular Formula | C20H28O2 | Melting Point | 165-166 °C |
| MSDS | USA | Flash Point | 186.2±21.3 °C |
| Symbol | GHS02, GHS07, GHS08 | Signal Word | Danger |
Names
| Name | Methandrostenolone |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 436.5±45.0 °C at 760 mmHg |
| Melting Point | 165-166 °C |
| Molecular Formula | C20H28O2 |
| Molecular Weight | 300.435 |
| Flash Point | 186.2±21.3 °C |
| Exact Mass | 300.208923 |
| PSA | 37.30000 |
| LogP | 4.04 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.572 |
| InChIKey | XWALNWXLMVGSFR-HLXURNFRSA-N |
| SMILES | CC12C=CC(=O)C=C1CCC1C2CCC2(C)C1CCC2(C)O |
| Storage condition | 2-8°C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 425 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 561 mg/kg/7Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 13 mg/kg
- SEX/DURATION :
- male 60 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- female 10 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - ovaries, fallopian tubes Reproductive - Maternal Effects - uterus, cervix, vagina
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- male 10 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Paternal Effects - other effects on male
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 7 mg/kg
- SEX/DURATION :
- female 14 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - ovaries, fallopian tubes Reproductive - Maternal Effects - uterus, cervix, vagina Reproductive - Fertility - other measures of fertility
MUTATION DATA - TEST SYSTEM :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg/10D (Intermittent)
- REFERENCE :
- VPITAR Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1932-41; V.11- 1952- Volume(issue)/page/year: 38(4),63,1980 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5642 No. of Facilities: 25 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 157 (estimated) No. of Female Employees: 72 (estimated)
- TEST SYSTEM :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg/10D (Intermittent)
- REFERENCE :
- VPITAR Voprosy Pitaniya. Problems of Nutrition. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1932-41; V.11- 1952- Volume(issue)/page/year: 38(4),63,1980 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5642 No. of Facilities: 25 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 157 (estimated) No. of Female Employees: 72 (estimated)
Safety Information
| Symbol | GHS02, GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H315-H360FD |
| Supplemental HS | May form explosive peroxides. |
| Precautionary Statements | P201-P210-P280-P308 + P313-P370 + P378-P403 + P235 |
| Hazard Codes | F,T |
| Risk Phrases | 60-61-11-19-38 |
| Safety Phrases | 53-45 |
| RIDADR | 3249 |
| WGK Germany | 3 |
| RTECS | BV8000000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2942000000 |
Customs
| HS Code | 2942000000 |
|---|
Articles28
More Articles| Gingival pain: an unusual side effect of ziprasidone. BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013) The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator... | |
| Screening for anabolic steroids in urine of forensic cases using fully automated solid phase extraction and LC-MS-MS. J. Anal. Toxicol. 38(9) , 637-44, (2014) A screening method for 18 frequently measured exogenous anabolic steroids and the testosterone/epitestosterone (T/E) ratio in forensic cases has been developed and validated. The method involves a ful... | |
| Mass spectrometric behavior of anabolic androgenic steroids using gas chromatography coupled to atmospheric pressure chemical ionization source. Part I: ionization. J. Mass Spectrom. 49(6) , 509-21, (2014) The detection of anabolic androgenic steroids (AAS) is one of the most important topics in doping control analysis. Gas chromatography coupled to (tandem) mass spectrometry (GC-MS(/MS)) with electron ... |
Synonyms
| 1-Dehydro-17a-methyltestosterone |
| Androsta-1,4-dien-3-one, 17β-hydroxy-17α-methyl- |
| Androsta-1,4-dien-3-one, 17β-hydroxy-17-methyl- |
| 1-Dehydro-17α-methyltestosterone |
| Androsta-1,4-dien-3-one, 17-hydroxy-17-methyl-, (17β)- |
| EINECS 200-787-2 |
| (17β)-17-Hydroxy-17-methylandrosta-1,4-dien-3-one |
| 17a-Methyl-17b-hydroxyandrosta-1,4-dien-3-one |
| 17-β-hydroxy-17-methyl-androsta-1,4-dien-3-one (9CI) |
| Metandienone |
| (17b)-17-Hydroxy-17-methylandrosta-1,4-dien-3-one |
| Nabolin |
| 17-β-hydroxy-17-methyl-androsta-1,4-dien-3-one |
| Methandienone |
| Methandrostenolone |
| MFCD00003650 |
